Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

iCAD Inc. (ICAD)

8.73   -0.08 (-0.91%) 10-01 16:13
Open: 8.81 Pre. Close: 8.81
High: 8.9142 Low: 8.48
Volume: 196,208 Market Cap: 200M
iCAD, Inc. is a medical technology company, which engages in the provision cancer detection and therapy solutions. The company is headquartered in Nashua, New Hampshire and currently employs 95 full-time employees. The firm provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging and Computed Tomography imaging. The company operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of its advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The firm sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers. The company develops and markets computer-aided detection (CAD) solutions for digital and film-based mammography systems. Its Axxent SPX Controller includes an optimized skin treatment arm customized for compatibility in confined patient treatment rooms in physician office-based facilities.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.171 - 9.216 9.216 - 9.253
Low: 8.529 - 8.588 8.588 - 8.637
Close: 8.726 - 8.817 8.817 - 8.89

Technical analysis

as of: 2020-10-01 3:34:59 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 12.41     One year: 13.96
Support: Support1: 8.48    Support2: 7.06
Resistance: Resistance1: 10.62    Resistance2: 11.95
Pivot: 9.40
Moving Average: MA(5): 8.85     MA(20): 9.47
MA(100): 10.39     MA(250): 9.43
MACD: MACD(12,26): -0.37     Signal(9): -0.26
Stochastic oscillator: %K(14,3): 8.93     %D(3): 11.08
RSI: RSI(14): 40.83
52-week: High: 15.31  Low: 5.91  Change(%): 27.3
Average Vol(K): 3-Month: 21897  10-Days: 32257

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ICAD has closed above bottom band by 25.6%. Bollinger Bands are 53.3% wider than normal. The large width of the bands suggest high volatility as compared to ICAD's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Thu, 01 Oct 2020
Intraoperative Radiation Therapy Systems Market Innovative Strategy by 2028 | Carl Zeiss Meditec AG, Inc., iCAD - Crypto Daily

Wed, 30 Sep 2020
InvestorChannel's Cancer Technologies Watchlist Update for Wednesday, September 30, 2020, 16:30 EST - InvestorIntel

Thu, 24 Sep 2020
The iCAD (NASDAQ:ICAD) Share Price Is Up 157% And Shareholders Are Boasting About It - Simply Wall St

Mon, 21 Sep 2020
How Does iCAD Inc (ICAD) Stock Rank on Wall Street? - InvestorsObserver

Sun, 20 Sep 2020
iCAD Responds to CMS' Finalized Radiation Oncology Alternative Payment Model - GlobeNewswire

Fri, 18 Sep 2020
iCAD's IORT Excluded from CMS's Radiation Oncology Alternative Payment Model - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Health Information Services
Shares Out. (M) 23
Shares Float (M) 20
% Held by Insiders 10.23
% Held by Institutions 28.59
Shares Short (K) 1,070
Shares Short P. Month (K) 1,310

Stock Financials

EPS -1.010
EPS Est This Year -0.540
EPS Est Next Year -0.220
Book Value (p.s.) 1.160
Profit Margin -69.88
Operating Margin -34.44
Return on Assets (ttm) -14.3
Return on Equity (ttm) -109.7
Qtrly Rev. Growth -24.0
Gross Profit (p.s.) 1.075
Sales Per Share 1.282
EBITDA (p.s.) -0.414
Qtrly Earnings Growth
Operating Cash Flow (M) -8
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -8.50
PEG Ratio
Price to Book value 7.40
Price to Sales 6.69
Price to Cash Flow -23.73

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.